Cannabis

Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.



Sign up for a 7-day FREE trial today!



Latest News in Cannabis

  • July 24, 2024

    Hemp Cos. Get Stay Of DEA Subpoenas Seeking Records

    A Texas federal judge on Wednesday stayed enforcement of U.S. Drug Enforcement Administration subpoenas seeking financial and other records from a group of hemp and vape sellers, who had argued earlier this week that the subpoenas were overbroad and unlinked to any federal investigation.

  • July 23, 2024

    Cooperator In Cannabis Bank Fraud Case Dodges Prison

    A U.K. national who testified against two businessmen accused of fooling banks into processing federally illicit transactions worth $150 million for California cannabis delivery company Eaze Technologies Inc. on Tuesday was spared from serving any time in prison.

  • July 23, 2024

    Cannabis Industry Stakeholders Weigh In On Rescheduling

    As the period for public comment on the Biden administration's proposal to reclassify marijuana came to a close Monday, anti-legalization activists, marijuana industry advocates and state cannabis regulators each submitted their thoughts on the potential policy shift.

  • July 23, 2024

    The Biggest Trademark Rulings Of 2024: A Midyear Report

    The U.S. Supreme Court rejected a California attorney's arguments that registering "Trump Too Small" as a trademark constituted speech protected by the First Amendment, and a split Ninth Circuit concluded district courts have the power to cancel trademark applications during litigation. Here's a look at some of the most notable trademark decisions so far this year.

  • July 23, 2024

    FDA's Multifaceted Role On Display In MDMA Therapy Scrutiny

    Ongoing deliberations at the U.S. Food and Drug Administration regarding MDMA-assisted therapy for post-traumatic stress disorder serves as a window into the intricate balance of scientific innovation and patient safety oversight, and offers crucial insights into regulatory nuances, say Kimberly Chew at Husch Blackwell and Kevin Lanzo at Pharmaka Clinical Consulting.

See more Cannabis news

Cannabis

Areas of Coverage

  • AGENCIES
  • U.S. Food & Drug Administration
  • Federal Trade Commission
  • Drug Enforcement Agency
  • U.S. Department of the Treasury
  • California Bureau of Cannabis Control
  • Department of Health & Human Services
  • Financial Crimes Enforcement Network
  • U.S. Securities and Exchange Commission
  • U.S. Commodity Futures Trading Commission
  • U.S. Department of Justice
  • State and international regulators
  • POLICY & REGULATION
  • SAFE Banking Act
  • STATES Act
  • Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
  • Section 280E of the Internal Revenue Code
  • Rohrabacher–Farr amendment
  • Bank Secrecy Act
  • Federal and state legislation
  • ENFORCEMENT
  • FDA and FTC actions over cannabis’s purported health claims
  • IRS actions against cannabis companies
  • Antitrust investigations
  • Financial regulatory actions
  • Federal criminal matters
  • State enforcement actions
  • LITIGATION
  • Civil RICO actions brought against cannabis concerns
  • Employment disputes
  • Securities class actions
  • Intellectual property matters
  • Consumer class actions
  • Bankruptcy
  • Tax disputes
  • Challenges to federal or state regulations
  • TRANSACTIONS
  • M&A activity involving cannabis companies
  • Commercial real estate transactions
  • PROFILES
  • Personnel moves
  • Profiles of law firm cannabis practices
  • Federal and state policymakers and lawmakers
  • General counsel interviews

READERSHIP

  • Cannabis lawyers at large to medium-sized law firms and boutiques
  • In-house counsel, compliance officers and executives at cannabis companies
  • Counsel and executives at venture capital and investment firms
  • Policymakers at federal and state agencies
  • Federal and state lawmakers
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!